BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 12, 2012
View Archived Issues
Ono Pharmaceutical updates progress of second quarter of fiscal 2012
Read More
Pevion Biotech launches new immune enhancement platform
Read More
Successful results reported for phase IIb trial of bremelanotide
Read More
XenoPort reacquires rights to Horizant
Read More
SGX-203 granted FDA fast track designation
Read More
Novel RNAi therapeutic significantly reduces triglycerides and LDL
Read More
Mutations in CYP26C1 associated with FFDD type IV
Read More
Kowa describes preclinical testing of novel cholesteryl ester transfer protein inhibitor
Read More
Researchers at Compugen present new fusion proteins
Read More
VS-5584 treatment inhibits cancer stem cells in vitro and in vivo
Read More
U.S. team prepares novel MAbs for cancer
Read More
New antibacterial agents synthesized by Canadian researchers
Read More
Novel BACE1/BACE2 inhibitors divulged by Merck & Co.
Read More
Scientists at Merck & Co. report novel MR antagonists
Read More
Biotron begins phase II BIT-225 trial in patients with HIV and HCV
Read More
Biota provides update on merger
Read More
Daiichi Sankyo submits supplemental NDA for Topotecin in Japan
Read More
FDA advisory committee votes on insulin degludec NDAs
Read More
Novel biomarker for the diagnosis of ACS presented by Japanese group
Read More
Myrexis board approves plan of complete liquidation and dissolution
Read More
Promising phase I results reported for subcutaneous MOR-103
Read More
AstraZeneca reports topline results from pivotal trials of naloxegol
Read More
Researchers in Australia present new agents for glaucoma
Read More
Pharma Eight presents novel agents for Alzheimer's disease
Read More
Pivotal HEAT Study of ThermoDox in primary liver cancer reaches target for unblinding
Read More